Kane Biotech Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was CAD 278,741 compared to CAD 267,493 a year ago. Operating loss was CAD 1.006 million compared to CAD 595,878 a year ago. Net loss was CAD 904,487 compared to CAD 505,397 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared. For the half year, total revenue was CAD 654,780 compared to CAD 723,633 a year ago. Operating loss was CAD 1.990 million compared to CAD 2.040 million a year ago. Net loss was CAD 1.812 million compared to CAD 1.869 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.